| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 173516 | 1,3,5-Triazine-2,4-diamine, 1-[4-fluoro-3-(trifluoromethyl)phenyl]-1,6-dihydro-6,6-dimethyl-, monohydrochloride | 0.0248868750898607 | 0.39082685 |
| NSC 219733 | N,N'-Bis(9-acridinyl)-1,6-hexanediamine | 0.0248868750898607 | 0.43982953 |
| NSC 281383 | Null | 0.0248868750898607 | 0.45698437 |
| NSC 612789 | Acrovestone | 0.0248868750898607 | 0.22410075 |
| NSC 634036 | 4-amino-3-bromo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazin-7-one | 0.0248868750898607 | 0.46129817 |
| NSC 643813 | 3'-O-(Carboxymethyl)-(Z)-Combretastatin 4-A, Na salt, hydrate [1:1:2] | 0.0283958753782624 | 0.31969435 |
| NSC 650263 | Null | 0.0283958753782624 | -0.053258325 |
| NSC 671161 | Hexadecylphospho(N-acetyl)-L-serine (NH4 salt) | 0.0283958753782624 | 0.24203997 |
| NSC 684981 | Null | 0.0283958753782624 | 0.10214666 |
| NSC 123461 | Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) | 0.0283958753782626 | 0.37087853 |